| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5955186 | Chest | 2013 | 7 Pages |
Abstract
The RDW is a readily available laboratory test result that may provide important, independent prognostic information at baseline and follow-up in patients with IPF. Further studies are warranted to validate this as a biomarker for IPF outcomes, as well as to define the biologic basis for this association.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Steven D. MD, FCCP, Taylor Reffett, A. Whitney MD, Chelsea P. Fischer, Oksana A. MD, FCCP, Shahzad MD, Nargues MD, FCCP, Michael J. ScD,